Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00396864What this trial is testingPhase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory LymphomaWho this might be right forCancerLymphomas Celgene 51
Testing effectiveness (Phase 2)Study completedNCT00460109What this trial is testingRituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 24
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Early research (Phase 1)Ended earlyNCT03685344What this trial is testingSafety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular LymphomaWho this might be right forDiffuse Large B-Cell LymphomaMantle Cell LymphomaFollicular Lymphoma ADC Therapeutics S.A. 13
Early research (Phase 1)Study completedNCT03922204What this trial is testingBispecific Antibody MCLA-145 in Patients With Advanced or Metastatic MalignanciesWho this might be right forAdvanced CancerSolid Tumor, AdultB-cell Lymphoma, Adult Merus B.V. 72
Testing effectiveness (Phase 2)Study completedNCT00121199What this trial is testingCombination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaWho this might be right forContiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage III Adult Diffuse Large Cell Lymphoma+1 more National Cancer Institute (NCI) 73
Early research (Phase 1)Looking for participantsNCT06544265What this trial is testingSynKIR-310 for Relapsed/Refractory B-NHLWho this might be right forB Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more Verismo Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT00726700What this trial is testingPegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Universität des Saarlandes 109
Testing effectiveness (Phase 2)Study completedNCT01241734What this trial is testingStudy of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCLWho this might be right forDiffuse Large B Cell Lymphoma Hackensack Meridian Health 18
Testing effectiveness (Phase 2)Study completedNCT00062114What this trial is testingYttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 84
Large-scale testing (Phase 3)Study completedNCT00052936What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Not applicableStudy completedNCT05972577What this trial is testingGeriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more Ohio State University Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT01231412What this trial is testingGraft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more Fred Hutchinson Cancer Center 174
Post-approval studies (Phase 4)Study completedNCT03190330What this trial is testingAssess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p DeletionWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell Johnson & Johnson Private Limited 75
Large-scale testing (Phase 3)Active Not RecruitingNCT04824092What this trial is testingTafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL PatientsWho this might be right forDiffuse Large B-cell Lymphoma Incyte Corporation 899